You are here

Global Cancer/Tumour Profiling Market To Be Driven By The Rising Global Incidence Of Cancer And The Use Of Biomarkers In Tumour Profiling In The Forecast Period Of 2021-2026

oliviamkts's picture
Submitted by oliviamkts on Tue, 06/21/2022 - 22:34

The new report by Expert Market Research titled, ‘Global Cancer/Tumour Profiling Market Report and Forecast 2021-2026’, gives an in-depth analysis of the global cancer/tumour profiling market, assessing the market based on its segments like by types of cancer, types of biosensors, technology, research application, clinical applications and major regions. The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter’s Five Forces models.

Request a free sample copy in PDF or view the report summary@ https://www.expertmarketresearch.com/reports/cancer-tumor-profiling-mark...

The key highlights of the report include:

Market Overview (2016-2026)

Historical Market Size (2020): USD7.8 Billion
Forecast CAGR (2021-2026): 10.2%
Forecast Market Size (2026): USD 14Billion
The growth of the cancer/tumour profiling market is being driven by a rise in cancer research and funding programs, as well as technical advances in profiling technology. Furthermore, the rising demand for personalized medicine and point-of-care diagnostics is projected to provide substantial growth opportunities for market participants during the forecast term.

Industry Definition and Major Segments

Cancer/tumour profiling is used to obtain insight into a patient’s cancer profile and make genomic changes that enable doctors to direct a patient to the best care option. As a result, profiling helps physicians to prevent potentially harmful treatments, reducing errors and trial procedures. Technological advances have aided the growth and application of tumour profiling tools, which can classify core characteristics of a patient’s cancer at an early stage and thereby direct the therapy selection for that patient. Personalized medicine has entered modern clinical practice and is transforming the way certain illnesses are diagnosed, categorized, and treated. It has become a central field of study in the healthcare sector.

Explore the full report with the table of contents@ https://www.expertmarketresearch.com/reports/cancer-tumor-profiling-market

The types of cancer can be divided into:

Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Melanoma
Others
The types of biosensors can be segmented into:

Genetic Biomarkers
Protein Biomarkers
Others
The cancer/tumour profiling market can be broadly categorised based on technology into:

Immunoassays
Next-Generation Sequencing
Polymerase Chain Reaction
In Situ Hybridization
Microarrays
Mass Spectrometry
Others
It finds its uses in the research and clinical applications.

Research applications can be further divided into:

Biomarker Discovery
Personalized Medicine
Clinical applications are further categorised into:

Diagnostics
Prognostics
Monitoring and Treatment
Screening
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Market Trends

Cancer/tumour profiling markets are now thriving as a result of technologically sophisticated healthcare infrastructures, the provision of advanced research and development services. Next-generation sequencing (NGS) is a specialized sequencing technology that can be used to precisely sequence tumour DNA. However, immunoassays segment accounted for the largest market share.

It is estimated that over 60% of new cancer cases in the world occur in regions such as Asia, Africa, and South and Central America, and that 70% of cancer deaths occur in these same regions. These regions may be the leading contributors to the growth and development of the global cancer/tumour profiling industry, owing to a large patient pool and potential customers. However, developing areas with high discretionary incomes, such as North America and Europe, are now at the top of the market.

Key Market Players

The major players in the market are Illumina, Inc. (NASDAQ: ILMN), Qiagen N.V., Neogenomic Laboratories, Inc., Sysmex Corporation, HTG Molecular Diagnostics, Inc., Helomics Corporation, Genomic Health, Inc., Caris Life Sciences, among Others. The report covers the market shares, capacities, expansions, investments and mergers and acquisitions, among other latest developments of these market players.

About Us:

Expert Market Research is a leading business intelligence firm, providing custom and syndicated market reports along with consultancy services for our clients. We serve a wide client base ranging from Fortune 1000 companies to small and medium enterprises. Our reports cover over 100 industries across established and emerging markets researched by our skilled analysts who track the latest economic, demographic, trade and market data globally.

At Expert Market Research, we tailor our approach according to our clients’ needs and preferences, providing them with valuable, actionable and up-to-date insights into the market, thus, helping them realize their optimum growth potential. We offer market intelligence across a range of industry verticals which include Pharmaceuticals, Food and Beverage, Technology, Retail, Chemical and Materials, Energy and Mining, Packaging and Agriculture.

Media Contact

Company Name: Claight Corporation
Contact Person: Steven Luke, Corporate Sales Specialist – U.S.A.
Email: sales@expertmarketresearch.com
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: https://www.expertmarketresearch.com

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.